This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Hospitals Immunization Vaccines 
pharmaphorum
SEPTEMBER 7, 2020
A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.
107 
Express Pharma
JUNE 20, 2023
The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.
105
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
AUGUST 3, 2021
The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.
145 
Express Pharma
SEPTEMBER 26, 2023
Indian Institute of Technology Mandi researchers, led by Dr Amit Prasad, Associate Professor, School of Biosciences and Bioengineering, has made strides in the development of vaccines against the pork tapeworm (T. Traditionally, tapeworm vaccines have been developed using products or antigens derived from tapeworm eggs or larvae.
111 
NY Times
SEPTEMBER 17, 2021
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
105 
NY Times
AUGUST 23, 2021
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
98 
pharmaphorum
DECEMBER 17, 2020
Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the roll-out of the shot from Pfizer/BioNTech. France’s Valneva begun the phase 1/2 clinical study of the inactivated vaccine candidate VLA2001 in sites across the UK, supported by the National Institute for Health Research (NIHR).
105 
pharmaphorum
DECEMBER 9, 2020
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. The post FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel appeared first on.
111 
pharmaphorum
MARCH 2, 2021
Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.
119 
pharmaphorum
OCTOBER 23, 2020
Is a century-old vaccine a ‘game-changer’ for COVID-19? This is especially true in the search for effective therapies to fight COVID-19, and a vaccine. In a worst-case scenario, misplaced hype could lead to a sudden rush to buy doses of the BCG vaccine. Understanding the link between COVID-19 and the BCG vaccine.
110 
Express Pharma
JUNE 15, 2023
The current influenza vaccines only provide protection against a limited number of strains, with the strains predicted to be dominant in the upcoming season selected for inclusion in the vaccines. Ultimately one of the biggest benefits of a universal influenza vaccine is that it could help to contain a potential pandemic.”
98 
Community Pharmacy
OCTOBER 27, 2023
While COVID-19 might not be as pressing of a problem as it was during the peak of the pandemic, the virus and its many variants still pose significant health risks that require updated vaccine protection to combat. rise, which previous year’s vaccines were not designed to protect against.
105 
pharmaphorum
SEPTEMBER 24, 2020
The UK could be the first country to carry out a COVID-19 “challenge trial” where healthy volunteers are deliberately infected with coronavirus to test vaccines, according to press reports. That vaccine is top of the World Health Organization’s list of vaccines in clinical development, which shows there are 38 potential shots in human trials.
98 
pharmaphorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
97 
Eye on FDA
NOVEMBER 17, 2020
Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. While vaccination may actually begin in December, the number of doses will be limited. In addition, the process of vaccination takes time.
NY Times
DECEMBER 17, 2020
An advisory group’s recommendation will mean millions more Americans can be inoculated, extending protection against Covid beyond major urban areas into rural and suburban regions.
98 
Pharmaceutical Technology
JUNE 10, 2023
Influenza vaccine 2 is under clinical development by Shanghai Institute of Biological Products and currently in Phase I for Pandemic Influenza. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the Influenza vaccine 2 LoA Report. The vaccine works by inducing the body's immune response.
40 
Pharmaceutical Technology
JUNE 10, 2023
Influenza vaccine 2 is under clinical development by Shanghai Institute of Biological Products and currently in Phase I for Pandemic Influenza. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the Influenza vaccine 2 LoA Report. The vaccine works by inducing the body's immune response.
40 
NY Times
MAY 22, 2021
An inoculation push, plagued with limited supplies and red tape, makes doses available to those who can pay for them. In a country with a struggling economy, most can’t.
58 
STAT
NOVEMBER 24, 2022
An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine.
317 
NY Times
AUGUST 31, 2021
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
97 
STAT
DECEMBER 12, 2022
to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. Without vaccines, the country would have experienced four times as many deaths, 1.5 The vaccines also saved the U.S. $1
349 
LifeProNow
APRIL 21, 2023
FDA amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 April 18, 2023: “The U.S.
130 
pharmaphorum
JANUARY 11, 2022
What HCPs think about mandatory vaccination. The practice of making vaccinations mandatory within a population has always been controversial. Historically, the first example of this was during the smallpox epidemic in the 1800s , when some European countries attempted to make vaccination against the disease compulsory.
98 
Express Pharma
JULY 7, 2023
Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions.
104 
pharmaphorum
NOVEMBER 25, 2021
The first patients are now being treated as part of a first-in-human trial of a vaccine, administered as a nasal spray, that aims to slow down the progression of Alzheimer’s disease (AD). Meanwhile researchers in Japan are also running preclinical studies of an intranasal tau vaccine.
98 
Pharmaceutical Technology
JUNE 24, 2022
As regulatory agencies gear up for another round of Covid-19 vaccine deliberations centered on emerging variants, Moderna has released data on its booster’s efficacy against Omicron subvariants. The mRNA-1273.214 booster contains the original Spikevax vaccine and a candidate targeting Omicron BA.1 1 variant of concern.
105 
LifeProNow
MAY 4, 2023
FDA approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,” said Peter Marks, M.D., According to the U.S.
130 
Digital Pharmacist
OCTOBER 26, 2022
Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.
98 
Pharmaceutical Technology
FEBRUARY 1, 2023
As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind. per 100,000.
64 
STAT
JULY 17, 2023
1 cause of hospitalization of babies in this country. Use of the antibody treatment, the brand name for which is Beyfortus, still needs to be recommended by the Advisory Committee on Immunization Practices, an independent expert panel that advises the Centers for Disease Control and Prevention. Read the rest…
246 
pharmaphorum
JANUARY 25, 2021
Merck & Co is to axe development of two COVID-19 vaccine candidates, focusing on development of two therapies instead following disappointing results in early trials. US-based Merck & Co said the decision followed findings from phase 1 clinical studies of the vaccines codenamed V590 and V591.
52 
STAT
FEBRUARY 22, 2023
This year’s flu shot generated relatively robust levels of protection, new data show, with the vaccine’s effectiveness ranging between about 45% and 55%, depending on the age group and the metric studied, such as whether there was protection against any infection or infection that was severe enough to require hospitalization.
246 
European Pharmaceutical Review
MARCH 9, 2023
Findings from research on the nasal monoclonal antibody “Based on our studies, we expect that Foralumab may work on all variants as it acts on immune effects,” Dr Weiner continued. Foralumab’s immune modulating response In 2020, Moreira researched how Foralumab modulates the immune response to reduce inflammation.
145 
NY Times
DECEMBER 23, 2020
Antibody treatments have shown promise, but tens of thousands of doses are sitting unused in hospital refrigerators.
52 
Express Pharma
APRIL 10, 2025
Research has reported that fear of needles constitutes about 20-50 per cent among children and 20-30 per cent among adults globally; often leading to missed vaccinations and delayed treatments. Currently, N FIS is used in multiple healthcare facilities, with adoption steadily increasing in hospitals and paediatric clinics.
82 
European Pharmaceutical Review
MAY 2, 2024
Sanofi noted that as a long-acting antibody, Beyfortus has been shown to provide rapid protection, helping to prevent lower respiratory tract disease caused by RSV without the immune system needing activation. Additionally, a study from Catalonia, Spain, pre-printed in The Lancet showed reductions of 87.6 percent and 90.1
122 
Digital Pharmacist
OCTOBER 5, 2022
Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services. Part D plans will also cover most vaccines, except for those covered in Part B.
epicur
JULY 12, 2023
These diagnostic imaging options were appealing to veterinary hospitals and clinics due to their comparative accessibility and low cost to operate. Immunotherapy With immunotherapy, targeted treatments are implemented that use a patient’s own immune system to fight cancer.
85 
Digital Pharmacist
SEPTEMBER 20, 2023
Breakdown of Medicare Types and Coverage Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services.
STAT
MAY 19, 2023
Food and Drug Administration advisory panel recommended the agency approve a Pfizer RSV vaccine, although the panelists expressed some safety concerns , STAT writes. The But on a second question — whether the available data support the safety of immunization with this vaccine — the committee voted 10-4.
222 
pharmaphorum
JUNE 1, 2022
The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. The positive feedback that has been generated by VR in training has also led to the creation of a ‘virtual hospital’ by Cardiff University. The training challenge. The more you know.
145 
Pharmacy Joe
JUNE 2, 2024
In this episode, I’ll discuss the use of tetanus immune globulin. Subscribe on iTunes , Android , or Stitcher Tetanus Immune Globulin can be part of successful tetanus post-exposure prophylaxis for certain patients as well as tetanus treatment. Peak concentrations are reached in 2 days and the half-life is 23 days.
52 
Express Pharma
JUNE 12, 2024
Digital health applications like e-diagnostics, e-pharmacy, telemedicine, wellness, and software as service-based hospitals are growing. Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals.
105
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content